z-logo
open-access-imgOpen Access
Genome-wide inactivation of porcine endogenous retroviruses (PERVs)
Author(s) -
Luhan Yang,
Marc Güell,
Dong Niu,
Haydy George,
Emal Lesha,
Dennis Grishin,
John Aach,
Ellen Shrock,
Weihong Xu,
Jürgen Poci,
Rebeca Cortazio,
Robert A. Wilkinson,
Jay A. Fishman,
George M. Church
Publication year - 2015
Publication title -
science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 12.556
H-Index - 1186
eISSN - 1095-9203
pISSN - 0036-8075
DOI - 10.1126/science.aad1191
Subject(s) - endogenous retrovirus , biology , genome , virology , reverse transcriptase , xenotransplantation , crispr , genome editing , transplantation , gene , genetics , rna , medicine , surgery
The shortage of organs for transplantation is a major barrier to the treatment of organ failure. Although porcine organs are considered promising, their use has been checked by concerns about the transmission of porcine endogenous retroviruses (PERVs) to humans. Here we describe the eradication of all PERVs in a porcine kidney epithelial cell line (PK15). We first determined the PK15 PERV copy number to be 62. Using CRISPR-Cas9, we disrupted all copies of the PERV pol gene and demonstrated a >1000-fold reduction in PERV transmission to human cells, using our engineered cells. Our study shows that CRISPR-Cas9 multiplexability can be as high as 62 and demonstrates the possibility that PERVs can be inactivated for clinical application of porcine-to-human xenotransplantation.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom